Ion Beam Applications S.A.
IBAB
Rank in Stocks
#11845
Ion Beam Applications S.A. (IBA) specializes in the creation, production, and... Ion Beam Applications S.A. (IBA) specializes in the creation, production, and maintenance of advanced medical equipment and software systems designed to combat cancer, operating across Belgium, the United States, and numerous other countries. Its operations are structured into two key divisions: Proton Therapy and Other Accelerators, and Dosimetry. The Proton Therapy and Other Accelerators segment is dedicated to the engineering, manufacturing, and upkeep of both clinical and industrial particle accelerators, including cutting-edge proton therapy apparatus. This division also furnishes comprehensive, ready-to-use systems for treating cancer with proton beams, a range of cyclotrons crucial for generating radioisotopes for PET and SPECT imaging, as well as industrial accelerators employed in sterilization and ionization processes. The Dosimetry segment offers instruments and expertise aimed at improving the precision and reducing errors in radiation therapy, medical imaging quality assurance, and calibration. IBA maintains a crucial research and development alliance with the Belgian nuclear research center, SCK CEN, to facilitate the development of Actinium-225 (225Ac), an innovative radioisotope with potential in cancer therapy, and collaborates with the University of Pennsylvania on pioneering research into ConformalFLASH technology. Established in 1986, the company's headquarters are located in Louvain-la-Neuve, Belgium.
Share Price
$17.98
Last synced: 2026-11-09
Market Cap
$524.23M
Change (1 day)
-1.42%
Change (1 year)
46.40%
Country
Stock data: Financial Modeling PrepΒ·Updated Β·Not investment adviceΒ·How we calculate this
Trade Ion Beam Applications S.A. (IBAB)
Category
Healthcare
EPS for Ion Beam Applications S.A. (IBAB)
EPS as of June 2026 TTM: $0.93
According to Ion Beam Applications S.A.'s latest financial reports, its current EPS (TTM) is $0.93. At the end of 2025 the company had an EPS of $0.50, an increase over its 2024 EPS of $0.32.
EPS history for Ion Beam Applications S.A. from 2001 to 2026
EPS at the end of each year
| Year | EPS | Change |
|---|---|---|
| 2026 (TTM) | $0.93 | 85.12% |
| 2025 | $0.50 | 56.39% |
| 2024 | $0.32 | -194.13% |
| 2023 | $-0.34 | -252.11% |
| 2022 | $0.23 | 52.44% |
| 2021 | $0.15 | -88.76% |
| 2020 | $1.32 | 350.91% |
| 2019 | $0.29 | -269.20% |
| 2018 | $-0.17 | -89.95% |
| 2017 | $-1.72 | -291.85% |
| 2016 | $0.89 | -62.04% |
| 2015 | $2.36 | 159.64% |
| 2014 | $0.91 | -539.89% |
| 2013 | $-0.21 | -28.91% |
| 2012 | $-0.29 | -92.95% |
| 2011 | $-4.12 | -1,382.83% |
| 2010 | $0.32 | -146.62% |
| 2009 | $-0.69 | 2.90% |
| 2008 | $-0.67 | -184.75% |
| 2007 | $0.79 | -49.59% |
| 2006 | $1.57 | 1,004.23% |
| 2005 | $0.14 | -58.17% |
| 2004 | $0.34 | -105.30% |
| 2003 | $-6.40 | 723.84% |
| 2002 | $-0.78 | 6.53% |
| 2001 | $-0.73 | 0.00% |
EPS for similar companies or competitors
| Company | EPS | EPS Difference | Country |
|---|---|---|---|
| $2.70 | 191.70% |
US
|
|
| $4.09 | 341.88% |
IE
|
|
| $9.45 | 920.96% |
US
|
|
| $2.37 | 156.05% |
US
|
|
| $1.77 | 91.23% |
US
|
Questions about Ion Beam Applications S.A.'s earnings per share (EPS)
What is Ion Beam Applications S.A.'s earnings per share (EPS)?
Ion Beam Applications S.A.'s earnings per share (EPS) over the last twelve months is $0.93, as of Jun 2026.
What was Ion Beam Applications S.A.'s earnings per share (EPS) in 2025?
In 2025, Ion Beam Applications S.A.'s earnings per share (EPS) was $0.50, 56.25% more than in 2024 ($0.32).
How has Ion Beam Applications S.A.'s earnings per share (EPS) changed since 2020?
From 2020 to 2025, Ion Beam Applications S.A.'s earnings per share (EPS) went from $1.32 to $0.50, an average decline of 17.65% a year.
How does Ion Beam Applications S.A.'s earnings per share (EPS) compare with similar companies?
Ion Beam Applications S.A.'s earnings per share (EPS) ($0.93) is lower than that of all 5 similar companies listed above. The highest among them is Stryker Corporation, with $9.45.